Landiolol and Organ Failure in Patients With Septic ShockTony Whitehouse, Hazel Smith, Julian Bion et al.|JAMA|2023Cited by 97
Pharmacokinetic (PK) and phase I study of sorafenib (S) for solid tumors and hematologic malignancies in patients with hepatic or renal dysfunction (HD or RD): CALGB 60301A. A. Miller, Mark J. Ratain, D. J. Murry et al.|Journal of Clinical Oncology|2007Cited by 16